CALIBERCOS INC-CL A (CWD) Fundamental Analysis & Valuation

NASDAQ:CWD • US13000T6047

Current stock price

1.35 USD
-0.06 (-4.26%)
Last:

This CWD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CWD Profitability Analysis

1.1 Basic Checks

  • In the past year CWD has reported negative net income.
  • CWD had a negative operating cash flow in the past year.
  • CWD had negative earnings in 4 of the past 5 years.
  • In the past 5 years CWD reported 4 times negative operating cash flow.
CWD Yearly Net Income VS EBIT VS OCF VS FCFCWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • The Return On Assets of CWD (-30.73%) is worse than 92.15% of its industry peers.
  • With a Return On Equity value of -606.55%, CWD is not doing good in the industry: 91.32% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -30.73%
ROE -606.55%
ROIC N/A
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWD Yearly ROA, ROE, ROICCWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

  • CWD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWD Yearly Profit, Operating, Gross MarginsCWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CWD Health Analysis

2.1 Basic Checks

  • CWD has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CWD has more shares outstanding
  • Compared to 1 year ago, CWD has a worse debt to assets ratio.
CWD Yearly Shares OutstandingCWD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CWD Yearly Total Debt VS Total AssetsCWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • CWD has an Altman-Z score of -1.17. This is a bad value and indicates that CWD is not financially healthy and even has some risk of bankruptcy.
  • CWD's Altman-Z score of -1.17 is on the low side compared to the rest of the industry. CWD is outperformed by 86.78% of its industry peers.
  • A Debt/Equity ratio of 13.94 is on the high side and indicates that CWD has dependencies on debt financing.
  • The Debt to Equity ratio of CWD (13.94) is worse than 90.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 13.94
Debt/FCF N/A
Altman-Z -1.17
ROIC/WACCN/A
WACCN/A
CWD Yearly LT Debt VS Equity VS FCFCWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • CWD has a Current Ratio of 1.47. This is a normal value and indicates that CWD is financially healthy and should not expect problems in meeting its short term obligations.
  • CWD has a Current ratio of 1.47. This is in the better half of the industry: CWD outperforms 67.36% of its industry peers.
  • A Quick Ratio of 1.47 indicates that CWD should not have too much problems paying its short term obligations.
  • CWD has a better Quick ratio (1.47) than 67.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
CWD Yearly Current Assets VS Current LiabilitesCWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CWD Growth Analysis

3.1 Past

  • CWD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -95.90%.
  • CWD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.85%.
  • CWD shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.07% yearly.
EPS 1Y (TTM)-95.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-795%
Revenue 1Y (TTM)-62.85%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-67.83%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.48% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -2.62% on average over the next years.
EPS Next Y67.34%
EPS Next 2Y40.45%
EPS Next 3Y26.49%
EPS Next 5YN/A
Revenue Next Year-38.88%
Revenue Next 2Y-11.97%
Revenue Next 3Y-2.62%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CWD Yearly Revenue VS EstimatesCWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
CWD Yearly EPS VS EstimatesCWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

1

4. CWD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CWD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CWD Price Earnings VS Forward Price EarningsCWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWD Per share dataCWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CWD's earnings are expected to grow with 26.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.45%
EPS Next 3Y26.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CWD Dividend Analysis

5.1 Amount

  • CWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CWD Fundamentals: All Metrics, Ratios and Statistics

CALIBERCOS INC-CL A

NASDAQ:CWD (3/16/2026, 8:17:10 PM)

1.35

-0.06 (-4.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-13
Earnings (Next)03-25
Inst Owners2.35%
Inst Owner Change393.47%
Ins Owners4.62%
Ins Owner Change0%
Market Cap9.33M
Revenue(TTM)24.66M
Net Income(TTM)-25.37M
Analysts80
Price Target7.14 (428.89%)
Short Float %0.9%
Short Ratio0.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-333.6%
Min EPS beat(2)-337.12%
Max EPS beat(2)-330.07%
EPS beat(4)0
Avg EPS beat(4)-670.63%
Min EPS beat(4)-1162.38%
Max EPS beat(4)-330.07%
EPS beat(8)2
Avg EPS beat(8)-428.51%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.48%
Min Revenue beat(2)-19.63%
Max Revenue beat(2)-15.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-19.63%
Max Revenue beat(4)28.56%
Revenue beat(8)6
Avg Revenue beat(8)88.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-34.48%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 2.23
P/tB 2.23
EV/EBITDA N/A
EPS(TTM)-19.59
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.98
FCFYN/A
OCF(TTM)-0.98
OCFYN/A
SpS3.57
BVpS0.61
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.73%
ROE -606.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 13.94
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z -1.17
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-795%
EPS Next Y67.34%
EPS Next 2Y40.45%
EPS Next 3Y26.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.85%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-67.83%
Revenue Next Year-38.88%
Revenue Next 2Y-11.97%
Revenue Next 3Y-2.62%
Revenue Next 5YN/A
EBIT growth 1Y20.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.11%
FCF growth 3YN/A
FCF growth 5Y-35.8%
OCF growth 1Y54.11%
OCF growth 3YN/A
OCF growth 5Y-35.8%

CALIBERCOS INC-CL A / CWD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CALIBERCOS INC-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to CWD.


Can you provide the valuation status for CALIBERCOS INC-CL A?

ChartMill assigns a valuation rating of 1 / 10 to CALIBERCOS INC-CL A (CWD). This can be considered as Overvalued.


What is the profitability of CWD stock?

CALIBERCOS INC-CL A (CWD) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for CWD stock?

The Earnings per Share (EPS) of CALIBERCOS INC-CL A (CWD) is expected to grow by 67.34% in the next year.